Idarubicin
An orally administered anthracycline antineoplastic. The compound has shown activity against BREAST NEOPLASMS; LYMPHOMA; and LEUKEMIA.
Year introduced: 1989
PubMed search builder options
Subheadings:
Tree Number(s): D02.455.426.559.847.562.050.200.300, D04.615.562.050.200.300, D09.408.051.059.200.300
MeSH Unique ID: D015255
Registry Number: ZRP63D75JW
Entry Terms:
- 4-Demethoxydaunorubicin
- 4 Demethoxydaunorubicin
- 4-Desmethoxydaunorubicin
- 4 Desmethoxydaunorubicin
- IMI-30
- IMI30
- IMI 30
- Idarubicin Hydrochloride
- Hydrochloride, Idarubicin
- NSC-256439
- NSC256439
- NSC 256439
Previous Indexing:
Pharmacologic Action: